# Cochrane

# Trusted evidence.

# Informed decisions.

# Library

# Better health.

# Analysis 2.5. Comparison 2: Fecal microbiota transplantation (FMT) versus control for maintenance of remission in ulcerative colitis (UC), Outcome 5: Any adverse events for maintenance of remission in UC

|Study or Subgroup|FMT Events|FMT Total|Control Events|Control Total|Weight|M-H, Random, 95% CI|Risk of Bias|
|---|---|---|---|---|---|---|---|
|Haifer 2022|0|4|0|6|Not estimable| |+ + + + + +|
|Sood 2019a|24|31|20|30|100.0%|1.16 [0.85 , 1.59]|+ ? + + + +|
|Total (95% CI)|35|36| | |100.0%|1.16 [0.85 , 1.59]| |

Total events: 24 (FMT) / 20 (Control)

Heterogeneity: Not applicable

Test for overall effect: Z = 0.93 (P = 0.35)

Favors FMT Favors control

Test for subgroup differences: Not applicable

# Risk of bias legend

(A) Random sequence generation (selection bias)

(B) Allocation concealment (selection bias)

(C) Blinding of participants and personnel (performance bias)

(D) Blinding of outcome assessment (detection bias)

(E) Incomplete outcome data (attrition bias)

(F) Selective reporting (reporting bias)

(G) Other bias

# Analysis 2.6. Comparison 2: Fecal microbiota transplantation (FMT) versus control for maintenance of remission in ulcerative colitis (UC), Outcome 6: Maintenance of endoscopic remission in UC

|Study or Subgroup|FMT Events|FMT Total|Control Events|Control Total|Weight|M-H, Random, 95% CI|Risk Ratio|Risk of Bias|
|---|---|---|---|---|---|---|---|---|
|Haifer 2022|4|4|0|6|23.3%|12.60 [0.86 , 185.05]| |+ + + + + +|
|Sood 2019a|18|31|8|30|76.7%|2.18 [1.12 , 4.23]| |+ ? + + + +|
|Total (95% CI)| |35| |36|100.0%|3.28 [0.73 , 14.74]| | |

Total events: 22 (FMT) / 8 (Control)

Heterogeneity: Tau² = 0.65; Chi² = 1.65, df = 1 (P = 0.20); I² = 40%

Test for overall effect: Z = 1.55 (P = 0.12)

Favors control Favors FMT

Test for subgroup differences: Not applicable

# Risk of bias legend

(A) Random sequence generation (selection bias)

(B) Allocation concealment (selection bias)

(C) Blinding of participants and personnel (performance bias)

(D) Blinding of outcome assessment (detection bias)

(E) Incomplete outcome data (attrition bias)

(F) Selective reporting (reporting bias)

(G) Other bias

Fecal transplantation for treatment of inflammatory bowel disease (Review)

Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.